Page last updated: 2024-08-24

gemcitabine and dinoprostone

gemcitabine has been researched along with dinoprostone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banerjee, S; Kaseb, AO; Kong, D; Mohammad, M; Mohammad, RM; Padhye, S; Sarkar, FH; Wang, Z	1
Ahmad, A; Ali, S; Banerjee, S; Dominiak, K; Padhye, S; Philip, PA; Sarkar, FH; Schaffert, JM; Wang, Z	1

Other Studies

2 other study(ies) available for gemcitabine and dinoprostone

Article	Year
Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer research, 2009, Jul-01, Volume: 69, Issue:13 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Cytochromes c; Deoxycytidine; Dinoprostone; Drug Synergism; Female; Gemcitabine; Humans; Mice; Mice, Inbred ICR; Mice, SCID; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms	2009
Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer research, 2010, May-01, Volume: 70, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Curcumin; Deoxycytidine; Dinoprostone; DNA, Complementary; DNA, Neoplasm; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; MicroRNAs; NF-kappa B; Oligonucleotides, Antisense; Pancreatic Neoplasms; PTEN Phosphohydrolase; Transfection; Triterpenes; Vascular Endothelial Growth Factor A	2010

Article

Year

Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.

Cancer research, 2009, Jul-01, Volume: 69, Issue:13

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Cytochromes c; Deoxycytidine; Dinoprostone; Drug Synergism; Female; Gemcitabine; Humans; Mice; Mice, Inbred ICR; Mice, SCID; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms

2009

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

Cancer research, 2010, May-01, Volume: 70, Issue:9

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Curcumin; Deoxycytidine; Dinoprostone; DNA, Complementary; DNA, Neoplasm; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; MicroRNAs; NF-kappa B; Oligonucleotides, Antisense; Pancreatic Neoplasms; PTEN Phosphohydrolase; Transfection; Triterpenes; Vascular Endothelial Growth Factor A

2010